Annals of Surgical Oncology Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Bree, E.
Right arrow Articles by Tsiftsis, D. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Bree, E.
Right arrow Articles by Tsiftsis, D. D.
Related Collections
Right arrow Other Breast
Annals of Surgical Oncology 9:663-667 (2002)
© 2002 Society of Surgical Oncology

ORIGINAL ARTICLES

Secretory Carcinoma of the Male Breast

Eelco de Bree, MD, John Askoxylakis, MD, Elpida Giannikaki, MD, Nikos Chroniaris, MD, Elias Sanidas, MD and Dimitris D. Tsiftsis, PhD

From the Departments of Surgical Oncology (EDB, JA, ES, DDT) and Pathology (EG), University Hospital, Medical School of Crete, Herakleion, Greece; and the Department of Pathology (NC), Venizeleio Hospital, Herakleion, Greece.

Correspondence: Address correspondence and reprint requests to: E. de Bree, Department of Surgical Oncology, University Hospital, PO Box 1352, 711 10 Herakleion, Greece; Fax: 30-810-542059; E-mail: debree{at}edu.uch.gr

Background: Secretory carcinoma is a distinctive and rare variant of breast carcinoma with a favorable prognosis because these tumors usually behave in an indolent manner. The occurrence of this type of breast cancer in males was studied.

Methods: An extensive literature survey concerning secretory breast cancer in males was performed. Data of one case treated in our institute were added.

Results: A total of 14 cases were identified, and our case was added to this series. The median age was 17 years. The duration of symptoms varied from 1 month to 21 years, and the tumor size was 1.2 to 4 cm. Surgical treatment varied from local excision only to modified radical mastectomy. Three patients received adjuvant treatment. Lymph nodes were involved in 3 of the 10 cases undergoing axillary lymph node dissection. The primary tumor was only 1.5 cm in diameter in two of those cases. None of the patients presented with systemic metastases. Only one male was reported to develop recurrence and consequently died of systemic disease.

Conclusions: Secretory breast cancer is very rare in males and seems to occur at a younger age in males than in females. A sufficient number of female cases have been reported with recurrence after local excision. Although in females lymph node metastases are rarely observed in secretory breast carcinoma smaller than 2 cm, in male patients nodal metastases might occur more frequently in smaller tumors. Therefore, mastectomy with sentinel lymph node biopsy or axillary lymph node dissection is recommended in any male case. Biological behavior seems to be similarly favorable in either sex.

Key Words: Secretory breast cancer • Male breast • Incidence • Treatment




This article has been cited by other articles:


Home page
 J Ultrasound MedHome page
S. H. Mun, E. Y. Ko, B.-K. Han, J. H. Shin, S. J. Kim, and E. Y. Cho
Secretory Carcinoma of the Breast: Sonographic Features
J. Ultrasound Med., June 1, 2008; 27(6): 947 - 954.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
S R Niveditha, P Bajaj, and A Nangia
Secretory carcinoma of the male breast
J. Clin. Pathol., August 1, 2004; 57(8): 894 - 894.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the Society of Surgical Oncology.